The report "MEA Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031", is projected to reach USD 0.22 billion by 2031 from USD 0.17 billion in 2025, at a CAGR of 4.6% during the forecast period.
Browse 150 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "MEA Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/mea-electrosurgery-market-109403621.html
The Middle East & Africa electrosurgery market is mainly influenced by the incidence of chronic diseases such as cancer and cardiovascular disorders, which cause an increase in surgical procedures. The increasing popularity of minimally invasive surgeries is one of the major factors for the rapid adoption of advanced electrosurgical instruments, which are highly precise, safer, and promote faster healing. Additionally, continuous innovation in advanced energy platforms and smoke management technologies has contributed to market expansion. However, the high cost of equipment and the lack of extensive reimbursement programs delay the adoption, especially in price-sensitive markets. In addition, uneven healthcare infrastructure, shortage of skilled surgeons, and limited access to advanced surgical technologies in several African countries are significant hurdles that have restrained the total growth potential of the market.
“Bipolar electrosurgical instruments accounted for the largest share by type of electrosurgical instruments in the MEA electrosurgery market in 2024.”
Based on product, the electrosurgery market comprises electrosurgical generators, electrosurgical instruments, electrosurgical accessories, and smoke evacuation systems. Among these, in 2024, electrosurgical instruments held the major share in the market. As these products offers various benefits such as enhanced safety and efficient vessel sealing. Their feature of being able to tightly seal blood vessels of up to 5 mm in diameter allows them to maintain effective hemostasis through high-volume surgeries. Incorporation of technological advancements, such as high-current delivery as well as thermo-fusion technologies, has led to higher precision and less spread of heat to adjacent tissues. Moreover, it has been found that bipolar instruments can work at lower power levels than monopolar ones, which is helpful in avoiding accidental burns and other complications. The expanding use of high-tech vessel sealing instruments and bipolar forceps in minimally invasive as well as highly complex surgeries has been the main factor in the strengthening of the segmental growth.
“The general surgery segment accounted for the largest share in the Middle East & Africa electrosurgery market, by surgery, in 2024.”
Based on surgery, the electrosurgery market includes segments such as general surgery, obstetric/gynecological surgery, urological surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, neurosurgery, oncological surgery, and other surgical procedures. Among these, in 2024, the general surgery segment accounted for the major share in the market. This is due to a large number of general surgical procedures carried out in various healthcare facilities. There are more and more people with chronic diseases like obesity, gastrointestinal disorders, and related metabolic diseases, which is driving up the need for surgical interventions. Electrosurgical instruments have become the mainstay of these procedures as they offer tissue dissection with great accuracy, hemorrhage control, and coagulation regulation, thus enhancing the operation's speed and result. Besides, general surgery is frequently the first method of treatment for several illnesses, hence continuously increasing the usage of electrosurgical instruments, generators, and accessories. The indispensable use of electrosurgery in handling complicated and frequently occurring interventions highlights the predominance of the general surgery segment.
“Rest of Middle East & Africa is anticipated to experience the most rapid growth throughout the forecast period”.
Segmented by region, the electrosurgery market includes GCC countries and the Rest of Middle East & Africa. The rest of Middle East & Africa region is expected to exhibit the highest growth rate during the forecast period. This region has a bigger population base, higher total surgical volumes, and the healthcare system is growing at a faster pace compared to the GCC countries. Countries like Iran, Israel, Egypt, Turkey, Yemen, and Morocco are seeing increased government spending on hospital infrastructure and surgical capacity, which can help the adoption of electrosurgical products on a broader scale. The increasing incidence of chronic diseases and a growing elderly population are other factors that contribute to the demand for general and minimally invasive surgical procedures. At the same time, a better understanding among the healthcare staff of the clinical and operational advantages of electrosurgery is leading to a higher rate of usage. Furthermore, the rise in the medical tourism sector in nations like Turkey is leading to increased demand for advanced surgical technologies, thereby giving more strength to the leading market position of the Rest of MEA region.
Key Market Players
The key players in the Middle East & Africa electrosurgery market are Medtronic plc (Ireland), Johnson & Johnson (Ethicon) (US), Olympus Corporation (Japan), B. Braun SE (Germany), CONMED Corporation (US), Boston Scientific Corporation (US), Smith and Nephew Plc (UK), Erbe Elektromedizin GmbH (Germany), BOWA-electronic GmbH & Co. KG (Germany), The Cooper Companies, Inc. (US), Zimmer Biomet (US), and Stryker Corporation (US), and among other players.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/